Myasthenia Gravis News

June 21, 2022June 21, 2022

Molecules in Blood Cells ID’d as Potential MG Diagnosis Biomarkers

Two molecules in blood cells may be potential biomarkers for diagnosing myasthenia gravis (MG), a study suggests. Researchers found levels to be lower in mononuclear cells — a mixture of ... Read more

June 16, 2022June 16, 2022

COVID-19 Vaccination Doesn’t Lead to Worsening MG, Study Reports

COVID-19 News, Myasthenia Gravis News

Two doses of the COVID-19 vaccine did not worsen symptoms in 200 people with myasthenia gravis (MG), with mostly injection site-related side-effects reported, matching those seen in the general population, ... Read more

June 14, 2022June 14, 2022

MG Symptoms Weigh on Life Quality, Particularly for Women

Myasthenia Gravis News

People with myasthenia gravis, particularly women, have a high symptom burden that considerably affects their health-related quality of life, but the disease’s human cost is rarely given adequate study, a systematic ... Read more

June 9, 2022June 9, 2022

Agreement Reached to Market Efgartigimod in Israel, Europe

Myasthenia Gravis News

Medison Pharma has entered into a pact with the global immunology company Argenx to bring efgartigimod to market in Israel and across several European countries for treating adult patients with ... Read more

June 7, 2022June 7, 2022

Vyvgart Opening to gMG Patients in UK Under Early Access Program

Myasthenia Gravis News

Vyvgart (efgartigimod alfa-fcab) is being made available to eligible adults with generalized myasthenia gravis (gMG) in the U.K. under an early access to medicines scheme (EAMS), Argenx, the therapy’s developer, ... Read more

June 2, 2022June 2, 2022

Virtual Meetings, Fundraisers, Events Set for MG Awareness Month

COVID-19 News, Myasthenia Gravis News

Myasthenia gravis (MG) affects 20 of every 100,000 people, according to the Myasthenia Gravis Foundation of America (MGFA), which is working to help educate the public about the rare disorder ... Read more

May 31, 2022May 31, 2022

Woman’s Repeat MG Flares Likely Due to Rare, Benign Heart Tumors

Myasthenia Gravis News

A woman with repeat myasthenia gravis (MG) flares was found to have several rare and benign tumors in her heart, a case study reported. According to its scientists, this case highlights ... Read more

May 26, 2022May 26, 2022

MG at Advanced Stage Follows Thymus Surgery in Older Man

Myasthenia Gravis News

A man developed myasthenia gravis (MG), which quickly progressed to an advanced stage, shortly after surgery to remove a tumor in the thymus gland, according to a report from China. Post-surgical ... Read more

May 24, 2022May 24, 2022

Woman Diagnosed With Ocular MG, Motor Neuropathy in Case Report

Myasthenia Gravis News

A woman was diagnosed with both ocular myasthenia gravis (MG) and a hereditary form of motor neuropathy, a condition affecting the nerves controlling the muscles in the body, according to ... Read more

May 19, 2022May 19, 2022

In Very Rare Cases, MG May Worsen After COVID-19 Vaccination

COVID-19 News, Myasthenia Gravis News

The Pfizer-BioNTech and the Moderna mRNA COVID-19 vaccines may, in very rare cases, cause myasthenia gravis (MG) symptoms to worsen in people with more severe disease, a small Japanese study ... Read more

May 17, 2022May 17, 2022

CAR T-cell Therapy Descartes-08 Continues to Show Promise in Trial

Myasthenia Gravis News

Descartes-08, Cartesian Therapeutics’ investigational CAR T-cell therapy, appears generally safe and markedly lessened symptom severity in the first five patients with generalized myasthenia gravis (gMG) enrolled in a Phase 1b/2a ... Read more

May 12, 2022May 12, 2022

Phase 3 Trials to Support Requests for Two New gMG Therapies, UCB Says

Myasthenia Gravis News

Both zilucoplan and rozanolixizumab, UCB’s experimental therapies for generalized myasthenia gravis (gMG), safely and effectively reduced symptom severity and their impact on daily activities, while improving patients’ quality of life, ... Read more

May 10, 2022May 10, 2022

Opdivo May Trigger Myasthenia Gravis, Case Report Indicates

Myasthenia Gravis News

Treatment with the immunotherapy Opdivo (nivolumab) may, in rare cases, trigger myasthenia gravis (MG), according to a Japanese case report. The patient, a 55-year-old woman, developed severe MG, which required admission to ... Read more

May 5, 2022May 5, 2022

Anti-thyroid Antibodies Tied to Specific Immune Profile in MG

Myasthenia Gravis News

Myasthenia gravis (MG) patients with antibodies against the thyroid gland have significantly more B-cells — the immune cells that produce antibodies — and fewer immune T-cells, a small single-center study ... Read more

May 5, 2022May 5, 2022

Organizations Rally to Help Ukrainian Rare Disease Patients

Myasthenia Gravis News

A Russian military plane crash near Tetiana Zamorska’s home in Kyiv, Ukraine, was a sign that it was time for her and her family to leave. The treacherous, 34-hour pilgrimage that ... Read more